| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 16.27B | 16.19B | 14.93B | 13.84B | 12.12B | 9.63B |
| Gross Profit | 3.86B | 3.85B | 3.46B | 3.14B | 2.62B | 1.95B |
| EBITDA | 2.08B | 2.04B | 1.72B | 1.63B | 1.29B | 646.18M |
| Net Income | 1.40B | 1.32B | 1.31B | 1.02B | 765.30M | 369.60M |
Balance Sheet | ||||||
| Total Assets | 8.32B | 10.53B | 9.47B | 8.59B | 7.37B | 6.51B |
| Cash, Cash Equivalents and Short-Term Investments | 2.73B | 2.68B | 2.34B | 1.98B | 1.35B | 1.26B |
| Total Debt | 224.98M | 1.50B | 1.21B | 710.84M | 413.94M | 817.03M |
| Total Liabilities | 2.75B | 4.67B | 4.38B | 3.52B | 3.15B | 2.90B |
| Stockholders Equity | 5.57B | 5.85B | 5.08B | 5.08B | 4.22B | 3.61B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 646.62M | 1.10B | 689.41M | 662.17M | 327.83M |
| Operating Cash Flow | 0.00 | 692.17M | 1.22B | 737.35M | 680.38M | 359.55M |
| Investing Cash Flow | 0.00 | -28.51M | 94.79M | -158.38M | -34.54M | -415.93M |
| Financing Cash Flow | 0.00 | -319.99M | -963.28M | 59.86M | -565.06M | 334.94M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥28.65B | 12.67 | ― | 2.93% | 11.53% | 23.23% | |
76 Outperform | ¥41.62B | 18.67 | ― | 1.92% | 20.81% | 68.06% | |
75 Outperform | ¥14.82B | 9.32 | ― | 3.14% | 3.58% | 0.23% | |
74 Outperform | ¥20.14B | 11.79 | ― | 2.40% | 21.57% | 129.44% | |
69 Neutral | ¥18.81B | 27.69 | ― | 0.52% | 50.92% | 46.61% | |
68 Neutral | ¥32.79B | 20.63 | ― | 4.58% | 4.58% | -15.00% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |